BPG is committed to discovery and dissemination of knowledge
Basic Study
©The Author(s) 2026.
World J Diabetes. Feb 15, 2026; 17(2): 111453
Published online Feb 15, 2026. doi: 10.4239/wjd.v17.i2.111453
Figure 1
Figure 1 Jiangtang Tiaozhi formula attenuated glycolipid metabolic disorder in vivo. A: Fasting glucose of mice during treatment (n = 8); B: Oral glucose tolerance test (OGTT) (n = 8); C: Body weight (n = 8); D: Triglyceride (n = 8); E: Total cholesterol (n = 8); F: Fasting glucose of mice after 8 weeks of treatment (n = 8); G: Area under the curve of OGTT (n = 8). aP < 0.05. bP < 0.01. cP < 0.001. NS: Not significant; JTTZF: Jiangtang Tiaozhi formula; OGTT: Oral glucose tolerance test; TG: Triglyceride; TC: Total cholesterol; AUC: Area under the curve.


Write to the Help Desk